New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models

Antiretroviral therapy (ART) controls human immunodeficiency virus 1 (HIV-1) replication and prevents disease progression but does not eradicate HIV-1. The persistence of a reservoir of latently infected cells represents the main barrier to a cure. “Shock and kill” is a promising strategy involving...

Descripción completa

Detalles Bibliográficos
Autores principales: Bricker, Katherine M., Chahroudi, Ann, Mavigner, Maud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402914/
https://www.ncbi.nlm.nih.gov/pubmed/34452425
http://dx.doi.org/10.3390/v13081560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402914/
https://www.ncbi.nlm.nih.gov/pubmed/34452425
http://dx.doi.org/10.3390/v13081560

Ejemplares similares